MedTrace Logo

Experimental Headache Induced by Vasoactive Intestinal Polypeptide

NCT00255320 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2005-12-09

No results posted yet for this study

Summary

We hypothesized that infusion of VIP may induce headache in healthy subjects and that VIP induced headache may be associated with dilatation of intra- and extracerebral blood vessels. To test this hypothesis, we performed a double blind placebo controlled crossover study in normal human volunteers and studied the effect on headache and cerebral as well as hemodynamic parameters.

Conditions

  • Healthy Volunteers, Headache, Migraine, Hemodynamics, VIP, SPECT, Ultrasound

Interventions

DRUG

VIP

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Jakob Møller Hansen, MD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-12-31
Completion
2004-06-30

Countries

  • Denmark

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00255320 on ClinicalTrials.gov